Skip to main content

Table 3 Distribution of microbial isolates by total body surface area and by days after admission

From: Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center

Isolated pathogensTotal%Total body surface area (%)days after admission
< 3940–4950–5960–6970–7980–89> 901–34–78–1415–30>  31
Total sampling numbers of culture specimen706 286511810815114294663878162362
Total number of culture-positive sample335100629435884625426283892151
 Rate of culture-positive (%)47.5 21.444.636.453.755.643.757.439.473.748.756.841.7
Total number of MDRO104 1917212019172693552
 Rate of MDRO in total culture-positive (%)31.0 0.968.716.320.219.218.316.31.95.88.733.750.0
Gram–positive cocci9729.0411161821111773122649
Staphylococcus sp.7522.431012151381423112336
S. aureus20.6110000000101
S. aureus (MRSA)3811.314894660211124
coagulase–negative staphylococcus216.3123461421765
 other Staphylococcus sp.144.2031231400266
Enterococcus sp.92.7112320140104
E. faecium (VRE)72.1001042010024
 Others61.8001021200015
Gram–positive bacilli41.2003010022000
Gram–negative bacilli4613.7137711894371220
Enterobacteriaceae
Klebsiella pneumoniae92.7003212101134
Klebsiella pneumonia (CRKP)82.4000411200125
Escherichia coli51.5010011200032
Enterobacter sp.41.2110020011011
E. cloacae (CRE)10.3001000010000
Proteus mirabilis41.2001020100022
Serratia marcescens30.9001010120010
Aeromonas hydrophila20.6010010001100
 Others103.0001124200406
Non-fermentative Gram-negative bacilli13239.401017223227241014134451
Acinetobacter sp.6318.808912131293692619
A. baumannii10.3000100001000
A. baumannii (IRAB)3610.70558666037188
A. baumannii (PDRAB)133.90020443010210
A. baumannii complex133.9032332031261
Pseudomonas aeruginosa339.9003510692301018
P. aeruginosa (PDR-PA)10.3000010000001
Stenotrophomonas maltophilia133.9012133322144
Chryseobacterium indologenes72.1010122120104
C. memingosepticum51.5000121112110
Chryseobacterium spp.41.2000112000004
Burkholderia cepacia30.9003000000120
Pseudomonas putida10.3000100001000
Moraxella osloensis10.3000001000010
Moraxella morganii10.3000000100001
Anaerobes41.2010002020002
Fungus5115.214011191341661028
Yeast4513.40301015134164826
 Yeast257.50108790022417
Candida spp.144.2020252313244
 Others61.8000032101005
MOLD61.8010140000222
  1. MDRO multiple drug-resistant organisms, MRSA methicillin-resistant S. aureus, VRE vancomycin-resistant Enterococcus, CRKP carbapenem–resistant K. pneumonia, CRE, carbapenem-resistant Enterobacteriaceae, IRAB imipenem-resistant A. baumannii, PDRAB pandrug-resistant A. baumannii, PDR-PA pandrug-resistant P. aeruginosa
  2. *PDRAB was defined as being resistant to aminoglycosides, antipseudomonal carbapenems, antipseudomonal fluoroquinolones, antipseudomonal penicillins+β-lactamase inhibitors, extended-spectrum cephalosporins, folate pathway inhibitors, penicillins+β-lactamase inhibitors, polymyxins, tetracycline
  3. *PDRPA was defined as being resistant to aminoglycosides, antipseudomonal carbapenems, antipseudomonal cephalosporins, antipseudomonal fluoroquinolones, antipseudomonal penicillins+β-lactamase inhibitors, monobactams, phosphonic acids, polymyxins